Viewing Study NCT03224702


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-26 @ 2:17 AM
Study NCT ID: NCT03224702
Status: COMPLETED
Last Update Posted: 2019-05-02
First Post: 2017-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MS200572-0009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators